BIO SB IDH1 R132H (IHC132), MMab
For In Vitro Diagnostic Use
Description
IDH1 R132H is a new mouse monoclonal antibody for immunohistochemistry from Bio SB. The IDH1 gene on chromosome 2q33.3 encodes for isocitrate dehydrogenase 1 (IDH1), located in the cytoplasm and the peroxisomes. This enzyme catalyzes NADPH production via oxidative decarboxylation of isocitrate to alpha-ketoglutarate in the Krebs citric acid cycle. Studies have shown that IDH1 mutation is an early step in gliomagenesis and has been reported to occur in grades II and III astrocytomas, oligodendrogliomas (OG), oligoastrocytomas (OA), and secondary GBM. Mutations involving IDH1 occur in a high proportion of diffuse gliomas, with implications on diagnosis. About 90% involve exon 4 at codon 132, replacing amino acid arginine with histidine (R132H). Preliminary studies comparing Immunohistochemistry (IHC) with IDH1-R132H mutation-specific antibodies have shown concordance with DNA sequencing and no cross-reactivity with wild-type IDH1 or other mutant proteins.
Synonymes
IDH1, anti-idh1, anti idh1, isocitrate dehydrogenase 1 NADP soluble, HEL 216, HEL S 26, IDCD, IDH, IDP, IDPC, PICD
Caractéristiques
- Type
- Mouse Monoclonal
- Clone
- IHC132
- Isotype
- IgG1
- Réactivité
- Paraffin, Frozen
- Localisation
- Cytoplasmic
- Contrôle
- Glioma, Glioblastoma, Astrocytoma with IDH1 R132H Mutation
- Usage prévu
- For In Vitro Diagnostic Use
Intéressé par ce produit ?
Indiquez la référence et le conditionnement souhaités, nous revenons vers vous rapidement.